- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02298582
Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly (FENTA)
Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly With or Without Background Treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a safety clinical trial. This trial is monocentric, open label, non-randomized.
Sixty elderly patients will be enrolled in this study, 30 with bedsore cares and 30 with rehabilitation sessions.
Six bedsore cares or rehabilitation sessions will be assessed for each subject. For each session, patient pain will be evaluated using a visual analogic scale VAS at different times, before session, 5 minutes then 20 minutes after the beginning of the session, and a last VAS 1 hour after the end of the session. During the two first sessions, patients do not receive Pecfent® to assess their basal pain. During the following four sessions, patients will receive transmucosal fentanyl, 10 minutes before care.
An evaluation of respiratory rate and of the level of sedation will occur at different time : after 5 minutes then 20 minutes of care, at the end of the care session,at half an hour then one hour after the care session.
At the end of sessions,
- The nurse or physiotherapist will assess their satisfaction regarding the objectives achieved during the session with a four points verbal descriptor scale (very satisfied, satisfied, not much satisfied, not satisfied). They will also evaluate at the end of the four last session their satisfaction regarding the convenience of the use of pecfent® and its contribution towards care.
- Patients will assess their satisfaction regarding the course of the session with a verbal descriptor scale (VDS) and their level of anxiety felt during the session with a VAS.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Isere
-
Grenoble, Isere, France, 38043
- University hospital of Grenoble
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Hospitalized geriatric patient requiring care or rehabilitation
- Patient with pain during treatment or mobilization. (VAS ≥ 4)
- Written Informed consent
Exclusion Criteria:
- All unstable fractures
- Confusion: unable to assess their level of pain using a VAS.
- Contraindications to PecFent ® (. Hypersensitivity to the active substance or to any of the excipients listed in section Composition Use in patients who had never received treatment for opioid severe respiratory depression or severe obstructive pulmonary disease.)
- Person under legal protection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intranasal fentanyl
|
During the two first sessions of care or rehabilitation, patients do not receive Pecfent® in order to assess their basal pain.
During the following four sessions, patients will receive transmucosal fentanyl, 10 minutes before care.
A titration of PecFent will be done at each session
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety of intranasal fentanyl as measured by the nature and frequency of adverse effects.
Time Frame: 5 days after the last intake of fentanyl.
|
The nature and frequency of adverse effects will be described.
The collection of adverse events will be first, with the collection of spontaneous patient complaints from nurses on the other hand, by systematic screening with the patient.
Monitoring of respiratory rate and level of sedation will also be set up.
|
5 days after the last intake of fentanyl.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effectiveness of intranasal fentanyl in procedural pain using a VAS (Visual Analogic Scale) of pain.
Time Frame: Evolution of the level of pain (VAS) since the beginning of care until one hour after the end of session (on average at 2 hours).
|
VAS will be evaluated during each session at t0, t0+15min, t0+30min, and 1hour after the session (on average at 2 hours)
|
Evolution of the level of pain (VAS) since the beginning of care until one hour after the end of session (on average at 2 hours).
|
Fentanyl impact on the goals of care as measured by a caregiver satisfaction scale.
Time Frame: At the end of session of care or rehabilitation (on average at 1 hour).
|
At the end of each session of care or rehabilitation, it will be proposed to the caregiver, a scale measuring its satisfaction regarding the objectives achieved during the session.
|
At the end of session of care or rehabilitation (on average at 1 hour).
|
Nurse or physiotherapist satisfaction regarding use of PecFent® as measured by a verbal descriptor scale
Time Frame: 1 hour after the last intake of fentanyl
|
Nurse or physiotherapist evaluation satisfaction regarding the convenience of the use of pecfent® and its contribution towards care using a verbal descriptor scale
|
1 hour after the last intake of fentanyl
|
Impact of PecFent® on patient feelings during care or rehabilitation sessions as measured by a verbal descriptor scale
Time Frame: At the end of Session of care or rehabilitation (on average at 1 hour).
|
Patient evaluation at the end of sessions: - Patient satisfaction regarding the course of the session with a VDS |
At the end of Session of care or rehabilitation (on average at 1 hour).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DCIC/13/67
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain Due to Certain Specified Procedures
-
Research Institute of Ophthalmology, EgyptRecruitingPain Due to Certain Specified ProceduresEgypt
-
Children's Hospital of Eastern OntarioUniversity of OttawaTerminatedPain Due to Certain Specified ProceduresCanada
-
BioceptiveUnknown
-
Children's Hospital of Eastern OntarioTerminatedPain Due to Certain Specified ProceduresCanada
-
Ankara City Hospital BilkentCompletedPain Due to Certain Specified Procedures | VibrationTurkey
-
University Hospital, LimogesWithdrawnNeuropathic Pain | Pain Due to Certain Specified Procedures
-
Antea FoundationCompletedPain | Cancer | Breakthrough Pain | Pain Due to Certain Specified Procedures | Terminal DiseaseItaly
-
St. Justine's HospitalCompletedChild | Pain Due to Certain Specified ProceduresCanada
-
TC Erciyes UniversityCompletedProstate Cancer | Pain Due to Certain Specified Procedures | BiopsyTurkey
-
St. Justine's HospitalToronto-Dominion Bank of Canada Funds for Clinical Research projects.CompletedImmune Deficiency | Autoimmune Rheumatologic Disease | Pain Due to Certain Specified Procedures | Child/Adolescent ProblemsCanada
Clinical Trials on intranasal fentanyl
-
University Hospital, MontpellierTerminated
-
University Children's Hospital, ZurichCompletedPain | Inhalation of Nitrous Oxide | Opioid Analgesic Adverse ReactionSwitzerland
-
University of Texas at AustinNot yet recruitingAnxiety | Facial Laceration
-
University Hospital, RouenNot yet recruiting
-
Defense and Veterans Center for Integrative Pain...DepomedCompletedMinor Procedural PainUnited States
-
TakedaCompleted
-
Intersect ENTCompleted
-
Bastyr UniversityNational Center for Complementary and Integrative Health (NCCIH)Completed
-
University of ArkansasNot yet recruitingPain | Anxiety | Acute Stress DisorderUnited States
-
University of Tennessee Health Science CenterCompleted